CAMPAIGN: Rare Disease (2023)
-
Canadian Rare Disease Patients Are Getting Impatient — Here’s Why
The Canadian Organization for Rare Disorders is urging the Canadian government to accelerate its National Strategy for Drugs for Rare Diseases implementation. In 2005, Ontario ombudsman Andre Marin issued a clarion call on behalf of a rare disease community that was struggling to make its voice heard. The issue was the Ontario government’s delay in...
-
Living with a Rare Disease Isn’t Easy, but Hope and Support Prevails
For the millions of Canadians living with rare diseases — along with their caregivers — support and community are available. One in 12 Canadians is living with a rare disease, which is defined as a disease that affects less than one person per 2,000 people. It’s estimated that there are over 7,000 rare diseases, and...
-
Why Ontario Needs a Rare Disease Strategy
Canada’s rare disease patients face many challenges, including long diagnosis journeys and barriers to treatment access — and it’s time to change that.
-
Boosting Awareness of This Rare Genetic Condition Can Save Lives
Increasing awareness of hypophosphatasia is essential for supporting Canadians living with this rare condition, along with their caregivers and doctors.
-
The Clock is Ticking for Ottawa to Deliver on Its Rare Disease Strategy
Canada desperately needs a rare disease strategy that’ll enable better patient care and access to treatment for those living with rare diseases. The start of a new calendar year signifies hope and new beginnings for many, but for the 1 in 12 Canadians affected by a rare disease, it marks another year without news of...
-
s Sponsored
Improving Canadian Rare Disease Patients’ Access to Treatment
Bayshore Specialty Rx is on a mission to help rare disease patients across Canada gain access to the treatments they need. Reducing the barriers to therapeutic access for rare disease communities People living with a rare disease face several challenges over their lifetime; delays in diagnosis for months or years after symptom onset, specialists can...
-
Early Treatment Redefines Quality of Life for Those with Spinal Muscular Atrophy (SMA)
The SMA journey is a lifelong marathon, and sustained treatment is vital for overcoming its peaks and valleys. Natalie Essex is an unstoppable nine year old from Delta, BC. Aside from enjoying school and a rich social life, Natalie weaves, sews, creates visual art, and sings in a children’s choir. She loves writing stories on...
-
s Sponsored
How to Optimize the $1 Billion Investment in a Rare Drug Strategy
An effective rare disease drug strategy for Canada will require infrastructure and research investments, alternative managed access pathways, and more. In 2019, the federal government committed $1 billion to invest in a rare disease drug strategy with an ongoing investment of $500 million annually. Following three years of nationwide multi-stakeholder consultations, the Canadian Organization for...
-
s Sponsored
Time is Muscle for Children Living with Duchenne Muscular Dystrophy
Six medications have been approved for Duchenne muscular dystrophy in the United States and Europe, while Canadians have nothing. One in every 5,000 boys worldwide is born with Duchenne, the most common fatal form of muscular dystrophy. The disease is relentless. It slowly weakens the body’s muscles, deteriorating the function of vital organs and ultimately...
-
Science Brings Hope to Canadians
Incyte believes that every challenge is the chance for a breakthrough Incyte is a global biopharmaceutical company on a mission to discover, develop and bring best-in-class medical advances to people suffering from diseases with limited options. The company was founded on the premise that investment in strong science and the relentless pursuit of R&D excellence...
Health Insight